• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Quest Diagnostics

Quest Diagnostics

Quest Diagnostics Inc DGX 3 Star

Last Price$75.81Day Change (%)0.80%
Open Price$75.59Day Change ($)0.60
Day Range74.76–75.9952-Week Range54.90–78.33

As of Fri 4/24/2015 5:58:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Fitch Affirms Quest Diagnostics' Ratings at 'BBB'; Outlook Stable

    Fitch Affirms Quest Diagnostics' Ratings at 'BBB'; Outlook Stable

  2. FDA Clears the Simplexa™ Group A Strep Direct Test from Focus Diagnostics, a Quest Diagnostics Business

    FDA Clears the Simplexa™ Group A Strep Direct Test from Focus Diagnostics, a Quest Diagnostics Business

  3. Quest Diagnostics to Launch Interactive Insights and IntelliTest Interactive Reports and Health Data Analytics Tools at HIMSS 2015

    Quest Diagnostics to Launch Interactive Insights and IntelliTest Interactive Reports and Health Data Analytics Tools at HIMSS 2015

  4. 5 improving stocks that Wall Street hates

    5 improving stocks that Wall Street hates

  5. Research and Markets: North American Revenue Cycle Management Market Report 2015-2019 - Integrated RCM & Standalone RCM

    Research and Markets: North American Revenue Cycle Management Market Report 2015-2019 - Integrated RCM & Standalone RCM

  6. Research and Markets: Global Drug Screening Market by Products and Services 2015-2019 - Immunoassay Analyzers, Chromatography, Breath Analyzers, Rapid Testing Devices, Assay Kits and Reagents

    Research and Markets: Global Drug Screening Market by Products and Services 2015-2019 - Immunoassay Analyzers, Chromatography, Breath Analyzers, Rapid Testing Devices, Assay Kits and Reagents

  7. Research and Markets: European Laboratory Information System (LIS) Market 2015-2019: Clinical Pathology Laboratory Information System, Anatomic Pathology Laboratory Information System

    Research and Markets: European Laboratory Information System (LIS) Market 2015-2019: Clinical Pathology Laboratory Information System, Anatomic Pathology Laboratory Information System

  8. Top 10 Purchases and Sales from Our Ultimate Stock-Pickers

    A group of top managers remains cautious and commits more capital to traditional defensive sectors, while taking advantage of a rising (and potentially overvalued) market to book some gains.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.